Sessioni Comunicazioni Orali


Advances in natural medicines and nutraceuticals

Friday, October 27th / 8.30-10.30
1Hydroxytyrosol inhibits EGFR signaling and enhances the antitumor effects of EGFR inhibitors in colorectal cancer
Donnini S., Terzuoli E., Ziche M.
2ANTI-CANCER PROPERTIES OF ERUCIN, AN ISOTHIOCIANATE PRESENT IN MANY EDIBLE PLANTS OF BRASSICACEAE FAMILY, ON HUMAN PANCREATIC ADENOCARCINOMA CELLS (ASPC-1): IS H2S THE HIDDEN PLAYER?
Martelli A., Citi V., Piragine E., Testai L., Pagnotta E., Ugolini L., Cinti S., Malaguti L., Breschi MC., Lazzeri L., Calderone V.
3NARINGENIN PROTECTS MYOCARDIUM AGAINST AGEING-RELATED INJURY
L. Testai, E. Piragine , I. Piano , A. Martelli , V. Citi , M.C. Gargini , E. Da Pozzo , C. Martini , M.C. Breschi , V. Calderone
4Nutraceutical properties of Arthrospira platensis and Isochrysis T. lutea rich diets in rats
Luceri C., Bigagli E., Cinci L., D'ambrosio M., Lodovici M., Niccolai A., Biondi N., Ridolfi L., Tredici M.
5INHIBITION OF SPONTANEOUS COLON TUMORIGENESIS IN PIRC RATS (F344/NTAC-APC AM1137), MUTATED IN APC, AND MECHANISTIC STUDIES IN VITRO AND EX-VIVO, SUGGEST POTENTIAL CHEMIOPREVENTIVE ACTIVITY OF A POMEGRANATE MESOCARP PREPARATION.
Tortora K., Femia AP., Romagnoli A., Luceri C., Khatib M., Mulinacci N., Giovannelli L., Caderni G.
6Potential of a flavonoid-rich extract from Bergamot juice as anticancer drug: preliminary data on its preventive effects in the Pirc rat (F344/NTac-Apc am1137), a genetic model of colorectal cancer
Navarra M., Femia AP., Romagnoli A., Tortora K., Luceri C., Maugeri A., Cirmi S., Ferlazzo N., Caderni G.
7Retinal bioavailability of curcumin after oral administration
Bucolo C., Platania CB., Fidilio A., Lazzara F., Piazza C., Geraci F., Salomone S., Drago F.
8EVALUATION OF GASTRIC ANTI-INFLAMMATORY ACTIVITY OF TANNINS FROM EUROPEAN CHESTNUT FRUITS (CASTANEA SATIVA MILL.): KERNEL FOR NUTRITION AND RIND FOR PHYTOTHERAPY
Sangiovanni E., Piazza S., Vrhovsek U., Fumagalli M., Colombo L., Mattivi F., Dell'agli M.
9β-Caryophyllene oxide as a new chemosensitizing agent to enhance sorafenib efficacy in liver cancer chemotherapy
Di Giacomo S., Sanchez-Vicente L., Di Sotto A., Monte MJ, Abete L., Mazzanti G., G. Marín JJ., Briz O.